Drug firms disclose more clinical trial data
Responding to public criticism and increased pressure from prestigious medical journals, pharmaceutical companies are publicly disclosing more information about clinical trials they sponsor. (Full article: 532 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
